Comparison of the Cozart DDS 801 on-site drug test device and gas chromatography/mass spectrometry (GC/MS) confirmation results of cannabis and cocaine in oral fluid specimens

References

• Raes E, Van den Neste T, Verstraete AG. Drug use, impaired driving and traffic accidents. In: Lopez D, Hughes B, Griffiths P, editors. EMCDDA Indights. European Monitoring Center for Drugs and Drug Addiction: Lisboa (Portugal), 2008;37–45.
   Google Scholar
• Parliament of Belgium. Wet tot wijziging van de wet betreffende de police over het wegverkeer, gecoördineerd op 16 maart 1968 (1) (Loi modifiant la loi relative à la police de la circulation routière, coordinnée le 16 mars 1968). 16 maart (mars) 1999. Belgisch Staatsblad (moniteur Belge) 30.3.1999
   Google Scholar
• Parlement français. Loi n 2003-87, Relative à la conduite sous l’influence de substances ou plantes classes comme stupéfiants. 3 février 2003.
   Google Scholar
• Steinmeyer S, Ohr H, Maurer J, Moeller MR. Practical aspects of roadside tests for administrative traffic offenders in Germany. Forensic Sci Int. 2001;121(1): 33–36. doi:10.1016/S0379-0738(01)00450-9
   PubMed Web of Science ®Google Scholar
• Ceder G. Drugged driving in Sweden – effects of new legislation concerning zero tolerance for narcotic drugs.Proceedings of the 15th international Conference of Alcohol, Drugs and safety (ICDTS), 22–26 May 2000. Stockolm (Sweden), CD-rom T2000, paper 509.55 forensics 2010.
   Google Scholar
• Parliament of Victoria. Road Safety (drug driving) acts 2003.111/2003; 2003.
   Google Scholar
• Kadehjian L. Legal issues in oral fluid testing. Forensic Sci Int. 2005;150(2–3):151–160.
   PubMed Web of Science ®Google Scholar
• European Monitoring Center for Drugs and Drug Addiction. The state of the drugs problem in Europe. Annual report 2011. Luxemburg:Publications office of the European Union.
   Google Scholar
• Instituto Nacional de Toxicología y Ciencias Forenses. Memoria 2010. Ministerio de justicia. gobierno de españa. http://institutodetoxicologia.justicia.es/wps/PA_ALFPROXY/proxy/alfresco/api/path/content/avm/INTToxicologico/www/avm_webapps/ROOT/noticia/2%20INTCF%20Memoria%202010.10ener.pdf
   Google Scholar
• Servei Català de Trànsit. Anuari estadístic d’accidents a catalunya 2010; 2011. Departament d’Interior Generalitat de Catalunya. http://www20.gencat.cat/docs/transit/Documents/Seguretat%20viaria/Anuari2010.pdf
   Google Scholar
• Arroyo A, Mora A, Sánchez M, Barbal M, Palahí M. Drogas de abuso en saliva de conductores: aspectos médicolegales. Revista Española de Medicina Legal. 2008:34(1):3–10.
   Google Scholar
• Mora A, Arroyo A, Barbal M, Palahi M, Barberia E. Driving under the effects of drugs of abuse: studies of oral fluid. Ann Tox Anal. 2009;(21):197–202.
   Google Scholar
• Biermann T, Schwarze B, Zeedler B,Betz P. On site testing of illicit drugs: the use of the drug-testing device “Toxiquit”. Forensic Sci Int. 2004;(143):21–25. doi:10.1016/j.forsciint.2004.01.013
   PubMed Web of Science ®Google Scholar
• Kacinko SL, Barnes AJ, Kim I, Moolchan ET, Wilson L, et al. Performance characteristics of the Cozart Rapiscan Oral Fluid Testing System for opiates in comparison to ELISA and GC/MS following controlled codeine administration. Forensic Sci Int. 2004;(141):41–48. doi:10.1016/j.forsciint.2003.12.003
   PubMed Web of Science ®Google Scholar
• Toennes S, Kauert G,Stein Meyer S, Moller MR. Driving under the influence of drugs-evaluation of analytical data of drugs in oral fluid, serum and urine, and correlation with impaired symptoms. Forensic Sci Int. 2005;(152):149–155. doi:10.1016/j.forsciint.2004.08.002
   PubMed Web of Science ®Google Scholar
• Toennes S, Steinmeyer S, Maurer HJ, Moeller MR, Kauert G. Screening of drugs of abuse in oral fluid –correlation of analysis results with serum in forensic cases. J Anal Toxicol. 2005;(29):22–27. doi:10.1093/jat/29.1.22.
   PubMed Web of Science ®Google Scholar
• Samyn N, de Boeck G, Verstraete AG. The use of oral fluid and sweat wipes for the detection of drugs of abuse in drivers. J Forensic Sci. 2002;(47):127–134.
   PubMedGoogle Scholar
• Siegel A. The role of saliva in drug monitoring. Ann NY Acad Sci. 1993;694:86–90.
   Google Scholar
• Cone, E, Jenkins A. Saliva drug analysis. In: Wong SHY, Sunshine I, editors Handbook of Analytical Therapeutic Drug Monitoring and Toxicology, CRC Press, London 1997.
   Google Scholar
• Drummer O. Review: pharmacokinetics of illicit drugs in oral fluid. Forensic Sci Int. 2005;(150):133–142. doi:10.1016/j.forsciint.2004.11.022
   PubMed Web of Science ®Google Scholar
• Verstraete A. Oral fluid testing for driving under the influence of drugs: history, recent progress and remaining challenges. Forensic Sci Int. 2005;(150):143–150.
   PubMed Web of Science ®Google Scholar
• http://www.rosita.org/ accessed 13-4-12
   Google Scholar
• Verstraete A, Raes E (Eds). ROSITA -2 project Final Report 2006:1–257.
   Google Scholar
• Pla Seguretat Viària 2008–2010. Servei Català de Trànsit. Generalitat de Cataluña. Barcelona.
   Google Scholar
• Avalaible from http://www.concateno.com
   Google Scholar
• Wille S, Samyn N, Ramirez M. de Boeck G. Evaluation of onsite oral fluid screening using Drugwipe-5, RapisSTAT and Drug Test 5000 for the detection of drugs of abuse in drivers. Forensic Science Int. 2010;(198):2–6. doi:10.1016/j.forsciint.2009.10.012
   PubMed Web of Science ®Google Scholar
• Pehrsson A, Gunnar T, Engblom C, Seppa H, Jama A, et al. Roadside oral fluid testing: comparison of the results of Drugwipe 5 and Drugwipe Benzodiazepines on site-tests with laboratory confirmation results of oral fluid and whole blood. Forensic Science Int. 2008;(175):140–148. doi:10.1016/j.forsciint.2007.05.022
   PubMed Web of Science ®Google Scholar
• Kolbrich E, Kim I, Barnes A, Moolchan ET, Wilson L, et al. Cozart Rapiscan oral fluid testing system: an evaluation of sensitivity, specificity and efficiency for cocaine detection compared with ELISA and GC-MS following controlled cocaine administration. J Anal Toxicol. 2003;27(7):407–411. doi:10.1093/jat/27.7.407
   PubMedGoogle Scholar
• Goessaert A, Pil K, Veramme J, Verstraete A. Analytical evaluation of a rapid on- site oral fluid test. Anal Bioanal Chem. 2010;(7):2461–2468. doi:10.1007/s00216-010-3463-8
   Web of Science ®Google Scholar
• Cirimele V, Villain M, Mura P, Bernard M. Kinzt P Oral fluid testing for cannabis: on-site OraLine IV s.a.t. device versus GC/MS. Forensic Sci Int. 2006;(161):180–184. doi:10.1016/j.forsciint.2006.01.020
   PubMed Web of Science ®Google Scholar
• Kim I, Barnes A, Schepers R, Moolchan E, Wilson L. et al Sensitivity and specificity of the Cozarty microplate EIA cocaine oral fluid at proposed screening and confirmation cut-offs. Clin Chem. 2003;49(9):1498–1503. doi:10.1373/49.9.1498
   PubMed Web of Science ®Google Scholar
• Crouch J, Walsh JM, Canglianeli L. Quintela O Laboratory evaluation and field application of roadside oral fluid collectors and drug testing devices. Ther. Drug Mon. 2008;(30):188–195. doi:10.1097/FTD.0b013e3181679249
   PubMed Web of Science ®Google Scholar
• Kintz P, Brunet B, Serra W, Villain M, Cirimele V. Evaluation of the Cozart DDSV test for cannabis in oral fluid. Ther Drug Monit. 2009;31:131–134. doi:10.1097/FTD.0b013e3181947916
   PubMed Web of Science ®Google Scholar
• Ramaekers J, Moeller MR, van Ruitenbeek P, Theunissen E, Schneider E, et al. Cognition and motor control as a function of delta 9 THC concentration in serum and oral fluid: limits of impairment. Drug Alcohol Dependence. 2006;(85): 114–122. doi:10.1016/j.drugalcdep.2006.03.015
   PubMed Web of Science ®Google Scholar
• Laloup M, Ramirez Fernandez M, Wood M, deBoeck G, Maes V, et al. Correlation of ∆9- tetrahydrocannabinol concentrations determined by LC-MS/MS in oral fluid and plasma from impaired drivers and evaluation of the on-site Dräger Drug Test. Forensic Sci Int. 2006(161):175–179. doi:10.1016/j.forsciint.2006.03.033
   PubMed Web of Science ®Google Scholar
• Department of Health and Human Services Substance Abuse and Mental Health Service Administration. Proposed revisions to mandatory guidelines for federal workplace drug testing programs 69. 2004; FR 19673.
   Google Scholar
• Speedy T, Baldwin D, Jowett G, Gallina M, Jehanli A. Development and validation of the Cozart DDS oral fluid collection device. Forensic Sci Int. 2007;170(2–3):117–120. doi:10.1016/j.forsciint.2007.03.038
   PubMed Web of Science ®Google Scholar
• Arroyo A, Amigo N, Carbone MT, Mora A, Pinto M, et al. Application of the Cozart DDS system to postmortem screening of drugs of abuse in vitreous humour. Forensic Toxicol. 2009;27:90–93.
   Web of Science ®Google Scholar
• Arroyo A, Sánchez M, Palahi M, Barbal M, Marron MT, et al. Applicability of an on-site test for its use in postmortem blood. Legal Med. 2011;13:55–67.
   PubMedGoogle Scholar
• Sanchez M, Arroyo A, Barbal M, Palahi M, Mora A. 2008. Cozart Rapsican oral fluid drug testing system validation by GC/MS analysis. Ann Toxicol Anal. 2008:20:131–136. doi:10.1051/ata/2009012
   Google Scholar
• Real Decreto 1428/2003. Código de la Circulación Español. Boletín Oficial del Estado nº306 de 23 Diciembre 2003.
   Google Scholar